期刊
JOURNAL OF RHEUMATOLOGY
卷 38, 期 8, 页码 1617-1621出版社
J RHEUMATOL PUBL CO
DOI: 10.3899/jrheum.100480
关键词
SUDDEN CARDIAC DEATH; VENTRICULAR TACHYARRHYTHMIAS; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; SYSTEMIC SCLEROSIS
类别
Objective. Cardiac involvement means a poor prognosis in systemic sclerosis (SSc). Conduction defects and arrhythmias are frequent in patients with SSc, and may result in sudden cardiac death. We tested whether electrophysiologic studies and implantation of cardioverter defibrillators are recommended when ventricular arrhythmias are present. Method. A cardioverter defibrillator was implanted in 10 patients with SSc who had heart involvement. Result. After 36 months, analysis of the device showed several episodes of ventricular tachycardia in 3 patients, which were promptly reverted by electrical shock delivery. Conclusion. In patients with SSc who are affected by ventricular arrhythimas, the implantation of a cardioverter defibrillator may prevent sudden cardiac death. (First Release June 1 2011; J Rheumatol 2011;38:1617-21; doi:10.3899/jrheum.100480)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据